With an estimated 32,000 Canadians diagnosed with lung cancer in 2024, Merck Canada aims to promote lung health with a new self-assessment tool. KIRKLAND, Quebec, February 04, 2025--(BUSINESS WIRE ...

With an estimated 32,000 Canadians diagnosed with lung cancer in 2024, Merck Canada aims to promote lung health with a new self-assessment tool. KIRKLAND, Quebec — Today on World Cancer Day, Merck ...

With an estimated 32,000 Canadians diagnosed with lung cancer in 2024, Merck Canada aims to promote lung health with a new self-assessment tool. Today on World Cancer Day, Merck Canada is ...

With an estimated 32,000 Canadians diagnosed with lung cancer in 2024, Merck Canada aims to promote lung health with a new self-assessment tool. Lung cancer is the most commonly diagnosed cancer ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

Merck KGaA (MKGAY) confirms “advanced discussions” with Springworks Therapeutics (SWTX) regarding a potential acquisition. “Merck also confirms that no legally binding agreement has been ...

Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...

Investing.com -- Merck &Company Inc (NYSE:MRK) shares tumbled more than 10% Tuesday after reporting mixed fourth-quarter results, with earnings falling short of expectations, revenue surpassing ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...